HALEON PLC SPON ADS

HALEON PLC SPON ADS

Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts recommend buying Haleon’s stock with a target price of $10.70, indicating growth potential.

Below Average

Dividend

HALEON PLC's projected dividend yield of 1.2% indicates a modest return on investment through dividends. If you invested $1000 you would be paid $12 a year in dividends (based on the last 12 months).

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You’ll Want to Watch This Stock

Why invest with Nemo?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

ABBV

AbbVie Inc.

Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.

AMGN

Amgen Inc.

Amgen is a global biotechnology company that focuses on discovering, developing and commercializing treatments for unmet medical needs.

AMRX

Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc. is an integrated generic and specialty pharmaceutical company that develops, manufactures, and markets generic and specialty pharmaceutical products.

Frequently asked questions